Table 1 General clinical characteristics of the study participants.
Total (N = 73) | Cryptogenic stroke (N = 48) | LAA stroke (N = 25) | p-valuea | |
|---|---|---|---|---|
Age, median (IQR) | 47 (9) | 46 (13.5) | 50 (5) | 0.009 |
Men, n (%) | 53 (72) | 34 (71) | 19 (76) | 0.78 |
NIHSS on admission, median (IQR) | 4 (4) | 3 (4) | 4 (4) | 0.94 |
NIHSS on admission 0–4, n (%) | 40 (55) | 27 (56) | 13 (52) | 0.99 |
NIHSS at 1 year, median (IQR) | 0 (0.25) | 0 (0) | 0 (2) | 0.15 |
Hypertension, n (%) | 37 (50) | 20 (42) | 17 (68) | 0.09 |
Diabetes, n (%) | 9 (12) | 4 (8) | 5 (20) | 0.26 |
Dyslipidaemia, n (%) | 47 (64) | 27 (56) | 20 (77) | 0.12 |
Preceding infection, n (%) | 5 (7) | 4 (8) | 1 (4) | 0.65 |
Cigarette smoking, n (%) | 43 (58) | 23 (48) | 20 (80) | 0.03 |
BMI ≥ 30, n (%) | 24 (33) | 13 (27) | 11 (44) | 0.19 |
Stroke in 1st degree relative, n (%) | 24 (33) | 11 (23) | 13 (52) | 0.04 |
hs-CRP on admission, (mg/L) median (IQR) | 2.4 (4.5) | 1.5 (3.7) | 3.3 (3.5) | 0.05 |
hs-CRP at 1 year, (mg/L) median (IQR) | 1.6 (2.4) | 1.2 (1.9) | 2.7 (2.8) | 0.02 |
